-->

Tech Seeker (TS)

AbCellera Biologics Inc
Profile last edited on: 3/11/2022

Full-stack, AI-powered therapeutic antibody drug discovery platform
TS Type
Small firm: Foreign
Status
Year Founded
2012
Last Involved Year
2021

Key People / Management

Location Information

2215 Yukon Street
Vancouver, BC V5Y 0A1
   (604) 559-9005
   www.abcellera.com

Public Profile

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
Canada
Employment
386
Revenue
N/A
Public/Private
Publicly Traded
Stock Info
NASDAQ : ABCL
Received SBIR $$
No

SBIR firms in the news

There are no news available.